TaiMed, Biologics TaiMed Biologics Announces Results from Late-Breaking Phase 2a Data on Long-Acting HIV Maintenance Therapy at CROI 2025 07.08.2025 - 18:05:59 TaiMed Biologics Taiwan New York California View original content:https://www.prnewswire.co.uk/news-releases/taimed-biologics-announces-results-from-late-breaking-phase-2a-data-on-long-acting-hiv-maintenance-therapy-at-croi-2025-302402916.html
